Company intelligence
MPN Research Foundation
We stimulate research in pursuit of new therapies, and eventually a cure, for myeloproliferative neoplasms. #ET #PV #MF
About MPN Research Foundation
The mission of MPN Research Foundation is to stimulate original research in pursuit of new treatments — and eventually a cure — for the blood cancers essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF), known collectively as myeloproliferative neoplasms (MPN). Through a combination of MPN cancer research, advocacy and education, we bring together patients, researchers, and clinicians around the common goal of realizing new treatment options and ultimately, a cure for MPNs. In addition, MPN Research Foundation promotes collaboration in the scientific community to accelerate MPN research and serves as a powerful patient advocacy group for MPN patients and their families.
Verified activity
Signals from MPN Research Foundation
6 published signals
Research & Knowledge
MPN Research Foundation reported that more than 29,000 patients, caregivers, and healthcare professionals worldwide have used the You and MPN educational resource since its launch.
Reported by MPN Research Foundation
Research & Knowledge
MPN Research Foundation reported that 91% of patients report that they intend to use what they learned to better self-manage their MPN.
Reported by MPN Research Foundation
Research & Knowledge
MPN Research Foundation reported that 9 in 10 visitors plan to discuss what they learned about treatment options with their doctor.
Reported by MPN Research Foundation
Legal & Regulatory
MPN Research Foundation reported that the FDA has approved Mimrylo (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera.
Reported by MPN Research Foundation
People
MPN Research Foundation is hiring for a permanent, full-time Philanthropy Manager or a temporary Registry Coordinator starting in October 2026.
Reported by David S.
People
MPN Research Foundation is hiring a Registry Coordinator for the MPN PROGRESSion Registry on a contract basis for the next four months.
Reported by David S.